PORTaL: Retrospective Multi-Center Study to Compare Perioperative Outcomes for Robotic-assisted Lobectomy With Those Associated With VATS and Open Lobectomy for Lung Cancer

Sponsor
Intuitive Surgical (Industry)
Overall Status
Completed
CT.gov ID
NCT03347825
Collaborator
(none)
7,000
1
28.9
241.8

Study Details

Study Description

Brief Summary

The main objective of this study is to evaluate and compare peri-operative outcomes of lobectomy compare with different approaches. The study aims to include patients with stage IA, IB, IIA, IIB and IIIA lung cancer that underwent lobectomy via robotic-assisted, VATS and open approach.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Robotic-assisted lobectomy using da Vinci Surgical System
  • Procedure: VATS (video assisted thoracic surgery)
  • Procedure: Open lobectomy

Detailed Description

This is a multi-center, retrospective chart review study of all consecutive lobectomies performed for clinical stage IA, IB, IIA, IIB and IIIA lung cancer, performed by participating surgeons at their respective institutions that meet all inclusion and exclusion criteria. All cases of lobectomy performed for clinical stages, IA, IB, IIA, IIB and IIIA lung cancer via robotic-assisted, VATS (video assisted thoracic surgery) and open approach that meet the study inclusion and exclusion criteria will be considered for inclusion in the study. The chart review and data collection will be performed in a reverse chronological order starting at 30 days prior to IRB approval of the study at the institution and going back to 2013 (i.e most current data in 2017 and chronologically going back through 2013). The retrospective chart review and data collection is anticipated to occur in two phases:

Baseline patient characteristics, perioperative and post-operative short term clinical and pathological outcomes data will be obtained from hospital records. Each participating institution will contribute approximately 100-800 cases from one or more surgeons. Since the data will have been de-identified, and is archival in nature, there will be no active subject recruitment and no patient consenting is required

Study Design

Study Type:
Observational
Actual Enrollment :
7000 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
A Retrospective Multi-Center Study for Evaluation of Clinical Outcomes With Lobectomy for Lung Cancer
Actual Study Start Date :
Feb 1, 2018
Actual Primary Completion Date :
Jul 1, 2020
Actual Study Completion Date :
Jul 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Robotic-assisted lobectomy

Pre-operative, intra-operative and post-operative clinical, surgical and oncological information will be obtained from institutional records for patients who underwent robotic-assisted lobectomy for lung cancer.

Procedure: Robotic-assisted lobectomy using da Vinci Surgical System
Robotic-assisted lobectomy

VATS (video assisted thoracic surgery) lobectomy

Pre-operative, intra-operative and post-operative clinical, surgical and oncological information will be obtained from institutional records for patients who underwent VATS lobectomy for lung cancer.

Procedure: VATS (video assisted thoracic surgery)
VATS (video assisted thoracic surgery)

Open lobectomy

Pre-operative, intra-operative and post-operative clinical, surgical and oncological information will be obtained from institutional records for patients who underwent open lobectomy for lung cancer.

Procedure: Open lobectomy
Open lobectomy

Outcome Measures

Primary Outcome Measures

  1. Chart review and data collection of clinical stage IB, IIA, IIB, IIIA cases [2013-2019]

    Compare peri-operative outcomes of robotic-assisted lobectomy with those associated with VATS and open lobectomy for lung cancer

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Subject is 18 years or older

  • Subject who has undergone elective robotic-assisted, VATS or open lobectomy for clinically diagnosed primary stage IA, IB, IIA, IIB and IIIA lung cancer, with or without neo-adjuvant therapy

Exclusion Criteria:
  • Subject with stage IIIB lung cancer

  • Subject who received lobectomy as an emergent procedure

  • Subjects who received lobectomy for metastatic cancer

Contacts and Locations

Locations

Site City State Country Postal Code
1 BaylorScott&White Dallas Texas United States 75093

Sponsors and Collaborators

  • Intuitive Surgical

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Intuitive Surgical
ClinicalTrials.gov Identifier:
NCT03347825
Other Study ID Numbers:
  • ISI-dVLob-001
First Posted:
Nov 20, 2017
Last Update Posted:
Feb 3, 2021
Last Verified:
Feb 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 3, 2021